Howard McLeod

Dr. Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is a Professor of Medicine at both Yale University and Utah Tech University and serves as the SVP, Clinical Affairs with GeneDx. He has implemented or advised implementation of precision medicine at integrated health systems, academic medical centers, and community practices in the USA and Internationally. Dr. McLeod was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Dr. McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies. Howard has published over 600 peer reviewed papers on precision medicine, pharmacogenomics, or cancer pharmacology with collaborators from over 40 countries. He continues to work to advance cutting-edge healthcare and early adoption of high impact innovation.